Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2354Neoplasms 1704Prostatic Neoplasms 1192Lung Neoplasms 922Colorectal Neoplasms 884Carcinoma, Non-Small-Cell Lung 866Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 574Multiple Myeloma 551Carcinoma, Hepatocellular 516Brain Neoplasms 515Neoplasm Metastasis 461Head and Neck Neoplasms 457Melanoma 414Ovarian Neoplasms 412Glioblastoma 402Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Stomach Neoplasms 376Uterine Cervical Neoplasms 362Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 335Sarcoma 324Hematologic Neoplasms 324Colonic Neoplasms 321Lymphoma 320Triple Negative Breast Neoplasms 289Carcinoma, Renal Cell 283Urinary Bladder Neoplasms 281Glioma 280

Interventions

Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Aneurysm × 1 year × Clear all
NCT06724029 2026-03-30

NEON

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
4,500 enrolled

Drug Resistant Epilepsy, Aneurysm, Arteriovenous Malformations, Depression, Facial Pain, Hematoma, Subdural, Hydrocephalus, Hydrocephalus, Normal Pressure, Moyamoya Disease, Muscle Spasticity, Neuralgia, Obsessive-Compulsive Disorder, Subarachnoid Hemorrhage, Tremor, Trigeminal Neuralgia, Dystonic Disorders, Hematoma, Epidural, Spinal

NCT06352710 2026-03-19

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment

Cantonal Hospital of St. Gallen

Recruiting
400 enrolled
CNS

Alzheimer Disease, Aneurysm, Brain Neoplasms

NCT02638701 2025-07-08

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

University of California, San Francisco

Phase 1/2 Recruiting
8 enrolled

Aneurysm, Vasculitis, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡